Swiatek's failed test 'ordeal' ends with one-month ban

LONDON - World No. 2 and five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for banned substance trimetazidine, the International Tennis Integrity Agency (ITIA) said on Nov 28.

She tested positive in an out-of-competition sample in August but the ITIA accepted that it was caused by contamination of her melatonin medication, which was manufactured and sold in Poland.

Swiatek, 23, had been taking it for jet lag and sleep issues and, as there was no significant fault or negligence, the ITIA offered the French Open champion a one-month suspension, which she accepted.

"The player was provisionally suspended from Sept 22 until Oct 4, missing three tournaments, which counts towards the sanction, leaving eight days remaining," the ITIA said in a statement.

"In addition, the player also forfeits prize money from the Cincinnati Open, the tournament directly following the test."